
REVXF
Healthcare · Medical Devices · $570.3M market cap
$13.550.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Feb 8, 2023 | After the close | 0.26 | 0.21 | -19.2% |
| Oct 26, 2022 | After the close | 0.23 | 0.23 | 0.0% |
| Aug 3, 2022 | After the close | 0.18 | 0.20 | +11.1% |
| Apr 27, 2022 | After the close | 0.15 | 0.18 | +20.0% |
| Feb 9, 2022 | After the close | 0.19 | 0.21 | +10.5% |
| Oct 20, 2021 | After the close | 0.17 | 0.18 | +5.9% |
| Aug 4, 2021 | After the close | 0.17 | 0.13 | -23.5% |
| Apr 22, 2021 | After the close | 0.12 | 0.14 | +16.7% |
| Feb 10, 2021 | After the close | 0.21 | 0.22 | +4.8% |
| Oct 21, 2020 | After the close | 0.15 | 0.11 | -26.7% |
| Aug 5, 2020 | After the close | 0.04 | 0.10 | +150.0% |
| Apr 21, 2020 | After the close | 0.08 | 0.08 | 0.0% |
| Feb 19, 2020 | After the close | 0.15 | 0.14 |
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare…
| -6.7% |
| Oct 23, 2019 | After the close | 0.08 | 0.12 | +50.0% |
| Aug 14, 2019 | After the close | 0.04 | 0.01 | -75.0% |
| Apr 15, 2019 | After the close | 0.04 | 0.05 | +25.0% |
| Feb 13, 2019 | After the close | 0.06 | 0.05 | -16.7% |
| Oct 24, 2018 | After the close | 0.05 | 0.12 | +140.0% |
| Aug 5, 2018 | After the close | 0.05 | 0.04 | -20.0% |
| Apr 19, 2018 | After the close | 0.04 | 0.04 | 0.0% |
| Feb 14, 2018 | After the close | 0.09 | 0.13 | +44.4% |